Rare diseases
Investigational molecules
Locations
Back to Spain1 063 clinical trials in Malaga, Spain across 4 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in SpainEnsayosClinicos.es(opens in a new tab)SpainTesting zongertinib compared to standard treatment in patients with early-stage non-small cell lung cancer with HER2 mutations after surgery
SpainA Study of Evorpacept Combined with Trastuzumab and Chemotherapy for Patients with Metastatic HER2-Positive Breast Cancer
SpainA study testing VH4524184 with emtricitabine and tenofovir alafenamide compared to dolutegravir and lamivudine in adults with HIV-1 who have not received treatment before
SpainStudy of IDP-121 with chemotherapy for patients with relapsed small cell lung cancer
SpainStudy of Trastuzumab Deruxtecan and Pertuzumab for Patients with HER2-Positive Metastatic Breast Cancer Who Have Not Received Prior Treatment
SpainTesting GSK5764227 combined with standard cancer treatments in patients with advanced solid tumors to evaluate safety and effectiveness
SpainA Study Comparing MB11 and Nivolumab in Adults With Previously Untreated Advanced or Metastatic Melanoma
SpainA Study of Atezolizumab and Bevacizumab Before and After Surgery in Patients with Liver Cancer at High Risk of Coming Back
SpainSpainStudy of ribociclib with or without chemotherapy for patients with hormone receptor positive, HER2 negative early breast cancer at intermediate risk
SpainA Study of JNJ-78278343 Compared to Placebo for Patients with Advanced Prostate Cancer That No Longer Responds to Hormone Treatment
SpainThe busiest research cities in the country
What the registry says about research in the country
Research focusing on innovative treatments for cutaneous lupus erythematosus and myasthenia gravis, evaluating new therapeutic approaches to improve patient outcomes.
Studies aim to assess novel therapies' effectiveness in reducing disease activity and improving daily living activities.
Innovative vaccine development studies targeting COVID-19, cytomegalovirus, and respiratory syncytial virus, focusing on prevention and immune response.
Research emphasizes safety and immunogenicity in various population groups.
Advanced studies in bladder cancer, colorectal cancer, and gastric cancer, evaluating targeted therapies and combination treatments.
Trials focus on improving survival rates and treatment responses in various cancer types.
Research examining new treatments for chronic rhinosinusitis and COPD, with emphasis on symptom management and exacerbation prevention.
Studies evaluate novel therapeutic approaches for chronic respiratory conditions.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
